T. Rowe Price
VC Fund
Baltimore, United States
T. Rowe Price is an investment management firm dedicated to funding technology startups. The firm serves individuals, financial intermediaries, and institutions and offers a full range of investment strategies across a broad spectrum: debt, equities, and private equities.
- Total investments:
- 403
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries T. Rowe Price invests in
Stages T. Rowe Price invests in
Countries T. Rowe Price invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anthony Wang
|
|||
Brian Rogers
|
|||
Christopher Alderson
|
|||
Corey Shull
|
|||
Dwayne Middleton
|
Investment Focus
Industry
- Biotechnology 82 (20%)
- Health Care 62 (15%)
- Medical 49 (12%)
- Software 38 (9%)
- Therapeutics 25 (6%)
Stage
- Series C 55 (14%)
- Series D 51 (13%)
- Series E 38 (9%)
- Series B 32 (8%)
- Funding Round 26 (6%)
Country
- United States 210 (52%)
- India 5 (1%)
- United Kingdom 4 (1%)
- China 3 (1%)
- Canada 3 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anthony Wang
Portfolio Manager - Vice President T. Rowe Price Group
|
Portfolio Manager - Vice President T. Rowe Price Group | Total investments: 2 | Find email | |
|
Brian Rogers
Retired Chairman
|
Retired Chairman | Total investments: 0 | Find email | |
|
Christopher Alderson
President, International Equity
|
President, International Equity | Total investments: 0 | Find email | |
|
Corey Shull
Vice President
|
Vice President | Total investments: 3 | Find email | |
|
Dwayne Middleton
Global Head of Fixed Income Trading
|
Global Head of Fixed Income Trading | Total investments: 0 | Find email | |
| See all 14 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hadrian
|
Hadrian is a precision manufacturing company that manufactures precision components to serve aerospace and defense clients. It builds autonomous, software-defined precision component factories that help its customers make rockets, satellites, jets, and eVTOLs. | $1.4B / Series D / Aug 06, 2026 | |
Xsight Labs
|
Xsight Labs is an Israeli company that develops technology for accelerating the next-generation, cloud-based, data-intensive workloads such as machine learning by offering new chipset designs that enhance scalability, performance and efficiency. | $300M / Series E / Jul 30, 2026 | |
K2 Space
|
K2 Space builds and supplies high-power satellite platforms designed for diverse orbital missions using vertically integrated hardware and manufacturing processes. The company focuses on developing large “Mega Class” satellites with enhanced power, payload capacity, and propulsion systems to support communications, sensing, and other spaceapplications. K2 Space offers engineered solutions for factory assembly, launch stacking, and orbital operations that aim to serve Low Earth Orbit, Medium Earth Orbit, and Geostationary missions. Its offerings include resilient spacecraft designs tailored to withstand harsh space environments and support scalable constellation deployments. | $500M / Series D / Jul 30, 2026 | |
Sila
|
Sila Nanotechnologies is an electronics company that offers new battery materials chemistry. It works directly with leading consumer electronics and automotive OEMs to help accelerate product roadmaps, and partners with battery manufacturers commercial cell production. The company was founded in 2011 and headquartered in California, United States. | $300M / Private Equity / Jul 21, 2026 | |
AdvanCell
|
AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. | $315M / Series D / Jul 15, 2026 | |
SambaNova
|
SambaNova develops artificial intelligence computing infrastructure that combines AI processors, hardware systems, and software for deploying and managing AI inference workloads. Its platform supports cloud, on-premises, and hybrid deployments, enabling organizations to run and manage large language models and AI applications using compatible APIsand orchestration tools. | $1B / Series F / Jul 08, 2026 | |
Airwallex
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $320M / Series H / Jun 25, 2026 | |
Ollin Biosciences
|
Ollin Biosciences operates as a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. | $330M / Series B / Jun 24, 2026 | |
Teamshares
|
Teamshares is a fintech platform for employee ownership. | $126.5M / Post-IPO Equity / Jun 19, 2026 | |
Ramp
|
Ramp is a financial technology company that develops software for corporate spend management, finance operations, and business payments. The company provides an integrated platform that combines corporate cards, expense management, accounts payable automation, procurement, travel booking, reimbursements, treasury services, and accountingautomation. Its software is designed to help organizations manage business spending, streamline financial workflows, and centralize finance operations within a single system. The platform enables businesses to issue and manage corporate cards, process vendor payments, track expenses, handle employee reimbursements, and automate accounting processes. It also incorporates artificial intelligence capabilities that assist with receipt matching, transaction categorization, policy enforcement, approval workflows, and financial reporting. These features are intended to reduce manual administrative work and improve visibility into organizational spending. | $750M / Series F / Jun 04, 2026 | |
| See all 403 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does T. Rowe Price invest in?
T. Rowe Price invests primarily in Biotechnology, Health Care and Medical startups, most often at Series C and Series D stage. Most of the 403 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact T. Rowe Price?
Public channels for T. Rowe Price include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at T. Rowe Price?
The team at T. Rowe Price includes Anthony Wang (Portfolio Manager - Vice President T. Rowe Price Group), Brian Rogers (Retired Chairman) and Christopher Alderson (President, International Equity), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
